Summary: Retatrutide is an investigational triple receptor agonist (GLP-1, GIP, and glucagon) that, based on Phase 2 trial data, produces significant appetite suppression and progressive weight loss, alongside gastrointestinal side effects that are most prominent during dose escalation
Consulting with a registered dietitian experienced in weight management medications can provide personalized guidance for optimizing energy while continuing to achieve weight loss or glycemic goals
A single freeze event can render your entire supply useless
201 In a preliminary study, 10 people with obstructive sleep apnea were found to have dysfunction of the delicate lining of blood vessels (the endothelium) compared with healthy controls, which improved to a level comparable with that of controls after a single 500-mg dose of intravenous vitamin C
What To Expect Several studies, like the SURMOUNT-2 trial using weekly injection of 10 mg or 15 mg of tirzepatide, found that obese patients with type 2 diabetes had an average weight loss of 15%
